Daily non-political popular news in brief.

The RNA drug revolution -- a new approach to gene therapy

RNA interference represents an innovative new strategy for using small RNA molecules to silence specific genes associated with disease processes, and a series of review articles describing the state-of-the-art and potential therapeutic applications of RNAi and microRNAs will begin with two review papers in the January 2008 issue (Volume 19, No. 1) of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. The papers are available free online.

Read more »

Keywords: rna, drug, revolution, approach, gene, therapy

« Previous | Next »

Similar news on "The RNA drug revolution -- a new approach to gene therapy":

1. Batten down the hatches against HIV
   02-20-2007 · EurekAlert!
   A promising approach to gene therapy involves short DNA fragments (interfering RNA) that bind to specific genes and block their "translation" into the corresponding, disease-related protein. A stumbling block has been the efficient and targeted delivery of RNA into the cells. Researchers led by Hongjie Dai at Stanford University have sucessfully used carbon nanotubes as a "means of transport," they write in "Angewandte Chemie."
   Similar news · Read more »
   
2. Gene Signatures Match Cancer And Other Diseases With Potentially Effective Drugs
   09-29-2006 · ScienceDaily
   In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language based on cells' distinctive gene activity profiles, or "signatures."
   Similar news · Read more »
   
3. Sirtris unveils promising, novel SIRT1 activators for treating diseases of aging
   11-28-2007 · EurekAlert!
   Sirtris Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, announced today that findings in the journal Nature demonstrate that Sirtris has developed novel drug candidates that offer a promising, new approach to treating diseases of aging, including type 2 diabetes, by targeting SIRT1, a gene that controls the aging process.
   Similar news · Read more »
   
4. Gene patenting -- steep cost for health care and patients
   05-07-2007 · EurekAlert!
   The drug trastuzumab (Herceptin) is used to treat HER2-positive breast cancer (a type of breast cancer that overexpresses the HER2 gene and accounts for about 25 percent of all breast cancers). Trastuzumab therapy improves the chances of survival; however, it has deleterious side effects and is expensive. Thus, it is important to accurately determine the patient's HER2 status.
   Similar news · Read more »
   
5. AVN944 inhibits IMPDH & induces apoptosis-related biomarkers in patients with hematologic cancers
   12-11-2006 · EurekAlert!
   IMPDH is highly upregulated in most hematological cancers and solid tumors -- an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function -- believed to result in tumor cell apoptosis at the right doses.
   Similar news · Read more »
   
6. Gene therapy for blindness clears hurdle in mice
   03-14-2007 · EurekAlert!
   University of Florida Genetics Institute researchers were able to use interfering RNA in experiments with mice to quiet a gene that plays a crucial role in a leading cause of inherited blindness. Disabling the gene is a step toward developing a gene therapy to treat people with retinitis pigmentosa, an inherited disease that attacks the light-sensing cells in the eye.
   Similar news · Read more »
   
7. AVN944 inhibits IMPDH and induces apoptosis-related biomarkers in patients with hematologic cancers
   12-11-2006 · EurekAlert!
   IMPDH is highly upregulated in most hematological cancers and solid tumors -- an essential role in cancer cell synthesis of DNA and RNA. Inhibition of IMPDH represents a new and important approach to treat cancer. In a Phase I trial of AVN944, AvalonRx identified a set of 34 genes. These gene markers correlate with the biochemical effects of AVN944 on protein function -- believed to result in tumor cell apoptosis at the right doses.
   Similar news · Read more »
   
8. Assembling the jigsaw puzzle of drug addiction
   01-04-2008 · EurekAlert!
   Using an integrative meta-analysis approach, researchers from the Center for Bioinformatics at Peking University in Beijing have assembled the most comprehensive gene atlas underlying drug addiction and identified five molecular pathways common to four different addictive drugs. This novel paper appears in PLoS Computational Biology on Jan. 4, 2008.
   Similar news · Read more »
   
9. 'Quiet revolution' may herald new RNA therapeutics
   01-21-2007 · EurekAlert!
   Scientists at the University of Oxford have identified a surprising way of switching off a gene involved in cell division. The mechanism involves a form of RNA, a chemical found in cell nuclei, whose role was previously unknown, and could have implications for preventing the growth of tumour cells.
   Similar news · Read more »
   
10. Firefly genes allow testing of new therapy against lymphoma
    12-19-2007 · EurekAlert!
    Researchers here have figured out a way to use a firefly gene to let them see just how effective a new drug combination actually is against some forms of cancer and its serious complication. The new study looked at ATLL, adult T cell lymphoma and leukemia, a form of cancer where it is particularly hard to gauge the disease's progress, and where the patients' prognosis is generally poor. There is now no widely effective therapy available to treat this disease successfully.
    Similar news · Read more »